General form of registration statement for all companies including face-amount certificate companies

Stockholders' deficit (Q1) (Tables)

v3.20.1
Stockholders' deficit (Q1) (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Stockholders' deficit [Abstract]    
Common Stock for Future Issuance
The Company has reserved common stock for future issuance as follows:

   
March 31, 2020
   
December 31, 2019
 
Conversion of Series E
   
1,760,903
     
1,760,903
 
Exercise of options to purchase common stock
   
7,891,833
     
7,791,833
 
Warrants to purchase common stock
   
18,046,310
     
16,981,854
 
Notes payable
   
4,722,795
     
4,437,500
 
Total
   
32,421,841
     
30,972,090
 
As of December 31, 2019, the Company has reserved approximately 31.0 million shares of common stock for future issuance as follows:

   
December 31, 2019
 
Conversion of Series E
   
1,760,903
 
Exercise of options to purchase common stock
   
7,791,833
 
Warrants to purchase common stock
   
16,981,854
 
Notes payable
   
4,437,500
 
Total
   
30,972,090
 
Activity of Warrants
On March 17, 2020, 1,003,232 warrants were issued to holders of warrants issued on May 6, 2019 due to dilutive impact of subsequent issuances.

   
Warrants
   
Weighted Average
Exercise Price
 
Warrants outstanding at December 31, 2019
   
16,981,854
   
$
3.23
 
Issued
   
1,064,456
     
1.81
 
Exercised
   
-
     
-
 
Warrants outstanding at March 31, 2020
   
18,046,310
   
$
3.05
 
The warrants are exercisable on the date of issuance and expire 24 months from the date of the consummation of a future IPO.

 
Warrants
   
Exercise Price
 
Warrants acquired on May 6, 2019
   
712,823
   
$
3.90
 
Issued
   
17,414,030
     
3.27
 
Exercised
   
(1,144,999
)(1)
   
3.50
 
Warrants outstanding at December 31, 2019
   
16,981,854
   
$
3.23
 

(1) Exercised warrants were converted at 1.1 shares per warrant for a total of 1,259,498 shares.